News Archives - Page 132 of 703

ThursdayOct 05, 2023 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Notable Progress in Development of High-Coherence Qubits

The fluxonium qubits that D-Wave has designed, manufactured, and operated demonstrate properties comparable to the best in scientific literature to date D-Wave has manufactured and tested fluxonium qubits in a two-dimensional circuit geometry, measuring several factors D-Wave owns one of the industry's largest quantum computer intellectual property portfolios, with more than 210 issued U.S. patents, and has published more than 100 peer-reviewed papers in leading scientific journals D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world's first commercial supplier of quantum computers, recently announced notable progress in its development of high-coherence qubits, with…

WednesdayOct 04, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Helps Facilitate Cross-border Trade Amid Growing U.S. Nearshoring Trend in Mexico

Mexico has become the United States’ leading international trading partner in recent months amid the country’s ongoing trade war with China Coincidental with Mexico’s growth as a nearshore commercial trade partner, the port at Laredo, Texas has become the most lucrative hub for cross-border commerce, recording $28.1 billion during this year’s first quarter Freight Technologies (aka Fr8Tech) is dedicated to aiding cross-border commerce through a suite of technological solutions targeting the relatively unorganized cross-border shipping and carrier industry Fr8Tech’s flagship platform, Fr8App, draws on artificial intelligence and machine learning technology to help match loads optimally and monitor shipments from origin…

WednesdayOct 04, 2023 9:45 am

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Secures $1.33 Million from Registered Direct Offering to Boost Commercial Development

Scinai Immunotherapeutics recently announced the closing of a registered direct offering, raising $1.33 million in gross proceeds The company intends to use the net proceed from the offering for, among others, research and development On its R&D agenda is the development and commercialization of novel innovative NanoAbs targeting a wide range of diseases with known and validated antibody drug targets This strategic approach is expected to shorten development timelines, reduce the budgetary requirements, and increase probability of drug approval The company has also expanded into the CDMO business to plug an existing gap in the market, raising recurring revenue as…

TuesdayOct 03, 2023 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Celebrates Tax-based Advantages in Rare Earth Processing Strategy

Rare earth supply chain innovator Ucore Rare Metals Inc. is working to strategically develop a North American-based supply chain for rare earth elements (“REEs”) that are vital to technologies ranging from smartphone to F-16 fighter jet parts China currently has a near-monopoly on REE refining and production, and international tech trade tensions in recent years have pushed Western nations to seek ways to revive their own REE industries Ucore has developed a proprietary RapidSX(TM) REE separation technology platform for refining rare earths, beginning with a strategic facility in development in Louisiana The company is celebrating announcement this month that it…

TuesdayOct 03, 2023 9:00 am

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Publishes NI43101-compliant Mineral Resource Estimate; Forecasts Mineral Value of Approximately $6.8 Billion

Eloro Resources recently published its initial NI-43101 compliance mineral resource estimate (“MRE”) The company’s long-awaited MRE revealed the existence of total inferred mineral resources amounting to 670 million tonnes – equivalent to nearly $6.8 billion in value Whilst impressive, Eloro’s management has revealed that the company has more exploratory drilling work to continue towards the site’s western edge, with further mineral resource estimate enhancement remaining likely Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company focused on developing its potential world-class Iska Iska silver-tin polymetallic property located in the Potosi Department in southern Bolivia, recently updated…

MondayOct 02, 2023 11:15 am

Meeting Phase 2 KPIs, Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Emerging as a Model for Sustainable Growth in the Oil & Gas Industry

Prospera in 2021 launched a new strategy to improve margins and oil and gas production while minimizing environmental impact Horizontal well-technology allows for increase in production and Prospera has now abandoned 60 vertical wells as part of its three-year LMRP to reclaim surface land and reduce environmental footprint that will see 200+ vertical wells abandoned Prospera this month completed the drilling of four horizontal wells of a ten-well multi-pad infill drill program that can add an additional ~750 bpd at a low decline to Prospera’s current 900+boepd With more than 42,000 cumulative acres across Cuthbert, Luseland and Heart Hills in…

MondayOct 02, 2023 10:30 am

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) Looks to Secure Property Rights at Zigzag Lithium Project Site; Announces Start of Drill Work at Ruby Graphite Mine

With EV sales skyrocketing around the world, securing lithium and natural graphite supplies has become a priority for battery manufacturers Reflex Advanced Materials has centered its efforts around catering to the lithium and graphite supply chains, with the company announcing that it had fulfilled the penultimate capital payment step needed to secure 100% ownership of its Ontario-based Zigzag lithium project The company also took the opportunity to announce the start of core exploratory drill work within the Montana-based Ruby Graphite project As auto sales staged a significant recovery in the United Kingdom this summer, electric vehicles led the surge. The…

MondayOct 02, 2023 9:45 am

SenesTech Inc. (NASDAQ: SNES) to Deploy ContraPest Solutions for Wastewater Facilities in Washington and California

SenesTech, with its proprietary biological solution for efficiently and safely reducing rat populations without killing, represents a remarkable new path to clean cities, businesses, and households According to pest industry figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States ContraPest offers a unique solution for wastewater facilities because it is non-poisonous and comes in a variety of formats that can help control rat populations where other approaches fall short SenesTech (NASDAQ: SNES), the rodent fertility control experts and the inventor of the only EPA-registered contraceptive for male and female rats, recently…

MondayOct 02, 2023 9:00 am

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Finalizes Rebrand to Reflect New Strategic Direction, Diversification

Scinai Immunotherapeutics, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, recently finalized a major rebrand, changing its corporate name from BiondVax Pharmaceuticals The rebrand is part of a series of steps to better reflect the company’s new direction and new developments aimed at new scientific breakthroughs Amir Reichman took over as CEO in March 2021 and together with the Board of Directors, began implementing a raft of changes aimed at redirecting the company’s focus and diversifying corporate risks Scinai is developing a pipeline of novel NanoAbs, with its development pipeline including NanoAbs for the treatment of…

FridaySep 29, 2023 11:15 am

PaxMedica Inc. (NASDAQ: PXMD) Releases Compelling Video: Progress Report on ASD and Hope for the Future

Autism Spectrum Disorder (“ASD”) has seen a staggering fourfold increase in the United States over the past two decades PaxMedica proudly stands as the sole publicly traded U.S. company singularly dedicated to addressing the challenges posed by Autism Our pioneering lead product, PAX-101, has shown significant promise in alleviating core Autism symptoms during early trials In 2024, we're poised to submit a New Drug Application (“NDA”) for PAX-101 to treat Human African Trypanosomiasis (“HAT”), a rare disease also known as African Sleeping Sickness, as part of the Neglected Rare Tropical Disease Program With NDA approval, we anticipate the potential to…

Site Search

Company Search

Category: News